Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFrontier Dev Regulatory News (FDEV)

Share Price Information for Frontier Dev (FDEV)

Share Price is delayed by 15 minutes
Get Live Data
461.50    5.00 (1.10%)
Bid:
455.50
Ask:
460.00
Spread: 4.50 (0.988%)
Market Cap: £160.29m
FDEV Live PriceLast checked at - London Stock Exchange

Intraday Frontier Dev Share Chart

Elite: Dangerous Alpha testing commences

12 Dec 2013 07:00

RNS Number : 3357V
Frontier Developments PLC
12 December 2013
 



12 December 2013

 

Frontier Developments plc 

 

Elite: Dangerous Alpha testing process commences

 

Frontier Developments plc (AIM: FDEV, "Frontier," the "Company"), a leading developer of video games with studios in Cambridge, UK and Halifax, Canada, announces the commencement on schedule of the Elite: Dangerous Alpha phase for eligible backers today.

 

This follows Frontier's announcement on 18 October 2013 that the Alpha phase would launch in December 2013.

 

At the end of 2012, Frontier raised £1.6 million via Kickstarter, the crowd funding service, and via its own website. The funds were raised specifically to develop Elite: Dangerous - the latest sequel to the Elite game that CEO David Braben originally co-authored published in 1984. Backers eligible to access the Alpha test phase in December 2013 are those who contributed £200 or more to develop Elite: Dangerous.

 

Alpha Phase One - Single Player Combat is a series of single player combat scenarios designed to test the combat systems in a close-to-final form. The Alpha Phase One process will give eligible backers an opportunity to test these aspects of the game and comment on the user experience.

 

David Braben, CEO of Frontier Developments, said:

 

"Starting the Elite: Dangerous Alpha process on schedule is a significant milestone for Frontier. Involving our backers from this stage of the development will give us access to valuable feedback that we will use to ensure the released game is as polished as possible."

 

 

Enquiries:

 

Frontier Developments

+44 (0)1223 394 300

David Braben, CEO

David Walsh, COO

Neil Armstrong, CFO

Canaccord Genuity 

+44 (0) 207 523 8000

Simon Bridges/Cameron Duncan

College Hill

+44 (0) 20 7457 2020

Kay Larsen/Adrian Duffield

 

 

About Frontier Developments

 

Frontier Developments plc is a leading independent game developer founded in 1994 by David Braben, co-author of the seminal 'Elite' game. Based in Cambridge, UK and Halifax, Nova Scotia, Canada, Frontier uses its proprietary 'Cobra' game development technology to create innovative games across videogame consoles, computers, smartphones and tablets.

 

Previous titles Frontier has created on include RollerCoaster Tycoon 3, Thrillville, LostWinds, Kinectimals, Kinect Disneyland Adventures. On 4 January 2013 Frontier raised £1.7 million via Kickstarter, the crowd funding website, and its own site to develop Elite: Dangerous. The studio is also working on a number of other titles, including Zoo Tycoon as a launch title for Microsoft's new Xbox One console.

 

 www.frontier.co.uk

 

 

About Cobra

Frontier's Cobra software technology has been developed and evolved since 1988. Initially conceived as a solution for the problem of easily porting the same game across different target hardware devices, Cobra today supports multi-core CPU and GPU architectures of PC, console, tablet and smartphone with a modular, high performance system offering of state of the art efficiency and visual fidelity that is applicable across a wide range of game genres.

 

Cobra incorporates a framework which enables rapid development of powerful game creation tools, which offer the ability to view, tweak and review changes to content (e.g. animations, audio, 3D models etc.) on target platforms in a live game session running on that platform, without the intervention of a programmer.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCBIBDDRGBBGXB
Date   Source Headline
7th Oct 20257:00 amRNSPDMR Dealing
7th Oct 20257:00 amRNSTransaction in Own Shares
7th Oct 20257:00 amRNSCompletion of £10 million Share Buyback Programme
6th Oct 20257:00 amRNSPDMR Dealing
6th Oct 20257:00 amRNSTransaction in Own Shares
3rd Oct 20257:00 amRNSPDMR Dealing
3rd Oct 20257:00 amRNSTransaction in Own Shares
29th Sep 20257:00 amRNSPDMR Dealing
29th Sep 20257:00 amRNSTransaction in Own Shares
26th Sep 20257:00 amRNSPDMR Dealing
26th Sep 20257:00 amRNSTransaction in Own Shares
25th Sep 20257:00 amRNSPDMR Dealing
25th Sep 20257:00 amRNSTransaction in Own Shares
24th Sep 20257:00 amRNSPDMR Dealing
24th Sep 20257:00 amRNSTransaction in Own Shares
23rd Sep 20253:35 pmRNSAnnual Report and Notice of AGM
23rd Sep 20257:00 amRNSPDMR Dealing
23rd Sep 20257:00 amRNSTransaction in Own Shares
22nd Sep 20257:00 amRNSPDMR Dealing
22nd Sep 20257:00 amRNSTransaction in Own Shares
19th Sep 20257:00 amRNSPDMR Dealing
19th Sep 20257:00 amRNSTransaction in Own Shares
18th Sep 20257:00 amRNSPDMR Dealing
18th Sep 20257:00 amRNSTransaction in Own Shares
15th Sep 20257:00 amRNSPDMR Dealing
15th Sep 20257:00 amRNSTransaction in Own Shares
12th Sep 20257:00 amRNSPDMR Dealing
12th Sep 20257:00 amRNSTransaction in Own Shares
11th Sep 20257:00 amRNSPDMR Dealing
11th Sep 20257:00 amRNSTransaction in Own Shares
10th Sep 20257:00 amRNSPDMR Dealing
10th Sep 20257:00 amRNSTransaction in Own Shares
10th Sep 20257:00 amRNSFY25 Financial Results
9th Sep 20257:00 amRNSPDMR Dealing
9th Sep 20257:00 amRNSTransaction in Own Shares
8th Sep 20257:00 amRNSPDMR Dealing
8th Sep 20257:00 amRNSTransaction in Own Shares
5th Sep 20257:00 amRNSPDMR Dealing
5th Sep 20257:00 amRNSTransaction in Own Shares
4th Sep 20257:00 amRNSPDMR Dealing
4th Sep 20257:00 amRNSTransaction in Own Shares
3rd Sep 20252:11 pmRNSNotice of FY25 Financial Results
3rd Sep 20257:41 amRNSTransaction in Own Shares
3rd Sep 20257:37 amRNSPDMR Dealing
2nd Sep 20257:00 amRNSPDMR Dealing
2nd Sep 20257:00 amRNSTransaction in Own Shares
1st Sep 20257:00 amRNSPDMR Dealing
1st Sep 20257:00 amRNSTransaction in Own Shares
29th Aug 20257:00 amRNSPDMR Dealing
29th Aug 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.